|“So these medicines are effective, but you may not hear about them. It’s certainly not something that’s FDA approved and so it flies under the radar.”- Dr. Scholz|
Standard of care is based on consensus-driven, evidence based guidelines that ensure optimal outcomes. Doctors use these guidelines to know how to treat their patients and insurance companies use these guidelines to know what they should cover for each patient. Unfortunately, the standard of care doesn’t allow for all possible options. Some men with prostate cancer are running out of options, what do they do when they have no more treatment options? What about men who don’t like the side effect profile of their current options? These men may be able to find a solution with off-label therapy. Off-label therapy is using FDA approved medications in an unapproved way.
Off-Label Therapies Mentioned in the Episode:
- Xtandi (High-Risk prostate cancer)
- Zytiga (High-Risk prostate cancer)
How to Find Off-Label Therapy:
- Search clinicaltrials.gov. If you are not eligible for the trial you can ask your doctor for a prescription.
- Visit an academic center. Academic centers do a lot of clinical trials and have high ethical standards and review boards.
- Find a specialist. Doctors who narrowly treat one type of disease can quickly identify what actually works.
Search clinicaltrials.gov for prostate cancer clinical trials
Visit the podcast website for full transcript: podcast.prostateoncology.com
Have questions or topics you think would be great for PROSTATE PROS? Email
Subscribe, rate, and review on Apple Podcasts
Check out more episodes on podcast.prostateoncology.com
Join the conversation, follow us on twitter: @keepprostate
The purpose of this podcast is to educate and inform. The information presented on this podcast and corresponding blog posted on prostateoncology.com/blog should not be used in place of a physician consult. Guests on the podcasts present their own opinions and conclusions, these views do not necessarily represent that of Prostate Oncology Specialists.